Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Top 5 Canadian Mining Stocks This Week: St.... June 14, 2025 Significant Uranium anomalies identified across the NT June 17, 2025 Munda Gold Mine Mining Progresses: First Blast June 19, 2025 Jp Cortez: Is America’s Gold Really There? US... June 17, 2025 Tech 5: OpenAI/Microsoft Talks Get Tense, SoftBank Floats... June 22, 2025 HyProMag USA Receives “Make More in America” Domestic... June 13, 2025 Cardiex Completes Placement & Launches Entitlement Offer May 30, 2025 Triumph Gold Announces the Acquisition of the Coyote... June 4, 2025 Freegold Ventures Limited – Results of the Annual... June 28, 2025 Resolution Minerals LtdTo Develop U.S. Government Engagement Strategy... June 18, 2025